help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishizawa, T.
Right arrow Articles by Yen, S.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishizawa, T.
Right arrow Articles by Yen, S.-H.
(American Journal of Pathology. 2003;163:1057-1067.)
© 2003 American Society for Investigative Pathology

Co-Localization of Glycogen Synthase Kinase-3 with Neurofibrillary Tangles and Granulovacuolar Degeneration in Transgenic Mice

Takashi Ishizawa*, Narahiko Sahara*, Koichi Ishiguro{dagger}, Jay Kersh*, Eileen McGowan*, Jada Lewis*, Michael Hutton*, Dennis W. Dickson* and Shu-Hui Yen*

From the Department of Neuroscience,* Mayo Clinic Jacksonville, Jacksonville, Florida, and the Mitsubishi Kagaku Institute of Life Sciences,{dagger} Machida, Japan

Transgenic mice expressing human tau with P301L missense mutation (JNPL3) develop progressive amyotrophy, neurofibrillary degeneration, and neuronal loss. Mating of JNPL3 with transgenic mice expressing mutant amyloid precursor protein (Tg2576) leads to bigenic (TAPP) mice with enhanced neurofibrillary pathology. TAPP and JNPL3 mice were studied with immunocytochemistry and immunoblotting with antibodies to glycogen synthase kinase-3 (GKS3) to determine whether the development of tauopathy is associated with activation or increased expression of GSK3, and when the observed changes occur with respect to neurofibrillary tangle (NFT) formation. Accumulation of GSK3{alpha}/ß phosphorylated at Y279/216 was observed in neurons containing NFTs and granulovacuolar degeneration (GVD), but not in normal neurons or neurons with pretangles. More GSK3 immunoreactive NFTs were detected in TAPP than JNPL3 mice, especially in the amygdala. These differences were notable only in old animals. There was no significant difference between animals with and without NFTs in the level of total, inactive, or Y216-phosphorylated (pY216)GSK3ß. No apparent GSK3 accumulation was detected in neurons in Tg2576 mice. There was also no significant difference in the distribution of GSK3 in lysates fractionated based on their solubility in various reagents, including the sarkosyl-insoluble fraction. The results suggest that the pY216 GSK3ß accumulates in NFT and GVD due to redistribution rather than increased expression or activation, and that pre-existence of tau abnormalities is required for APP/Aß to exert their effects on tau pathology in TAPP mice.




This article has been cited by other articles:


Home page
 J. Neurosci.Home page
Y. Wen, E. Planel, M. Herman, H. Y. Figueroa, L. Wang, L. Liu, L.-F. Lau, W. H. Yu, and K. E. Duff
Interplay between Cyclin-Dependent Kinase 5 and Glycogen Synthase Kinase 3{beta} Mediated by Neuregulin Signaling Leads to Differential Effects on Tau Phosphorylation and Amyloid Precursor Protein Processing
J. Neurosci., March 5, 2008; 28(10): 2624 - 2632.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. Terwel, D. Muyllaert, I. Dewachter, P. Borghgraef, S. Croes, H. Devijver, and F. Van Leuven
Amyloid Activates GSK-3{beta} to Aggravate Neuronal Tauopathy in Bigenic Mice
Am. J. Pathol., March 1, 2008; 172(3): 786 - 798.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. C. Carroll, E. R. Rosario, L. Chang, F. Z. Stanczyk, S. Oddo, F. M. LaFerla, and C. J. Pike
Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice
J. Neurosci., November 28, 2007; 27(48): 13357 - 13365.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Leroy, A. Bretteville, K. Schindowski, E. Gilissen, M. Authelet, R. De Decker, Z. Yilmaz, L. Buee, and J.-P. Brion
Early Axonopathy Preceding Neurofibrillary Tangles in Mutant Tau Transgenic Mice
Am. J. Pathol., September 1, 2007; 171(3): 976 - 992.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
E. Rockenstein, M. Torrance, A. Adame, M. Mante, P. Bar-on, J. B. Rose, L. Crews, and E. Masliah
Neuroprotective Effects of Regulators of the Glycogen Synthase Kinase-3{beta} Signaling Pathway in a Transgenic Model of Alzheimer's Disease Are Associated with Reduced Amyloid Precursor Protein Phosphorylation
J. Neurosci., February 21, 2007; 27(8): 1981 - 1991.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Plattner, M. Angelo, and K. P. Giese
The Roles of Cyclin-dependent Kinase 5 and Glycogen Synthase Kinase 3 in Tau Hyperphosphorylation
J. Biol. Chem., September 1, 2006; 281(35): 25457 - 25465.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Tan, L. Geng, E. M. Yazlovitskaya, and D. E. Hallahan
Protein Kinase B/Akt-Dependent Phosphorylation of Glycogen Synthase Kinase-3{beta} in Irradiated Vascular Endothelium
Cancer Res., February 15, 2006; 66(4): 2320 - 2327.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
K. A. Ryan and S. W. Pimplikar
Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain
J. Cell Biol., October 24, 2005; 171(2): 327 - 335.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
W. Noble, E. Planel, C. Zehr, V. Olm, J. Meyerson, F. Suleman, K. Gaynor, L. Wang, J. LaFrancois, B. Feinstein, et al.
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo
PNAS, May 10, 2005; 102(19): 6990 - 6995.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.